Elevated MMP2 mRNA expression in MASH samples has been reported previously [45] and might be explained by RECK expression (see ADAM10 and ADAM17 above), a negative regulator of MMP2 and MMP9 [37], which is reduced in samples from patients with MASLD [38]. The gene discussed is ADAM17; the disease is metabolic dysfunction-associated steatohepatitis.